» Articles » PMID: 38275655

High Tyrosol and Hydroxytyrosol Intake Reduces Arterial Inflammation and Atherosclerotic Lesion Microcalcification in Healthy Older Populations

Overview
Date 2024 Jan 26
PMID 38275655
Authors
Affiliations
Soon will be listed here.
Abstract

Aging is an important risk factor for cardiovascular diseases and convincing data have shown that chronic low-grade inflammation, which develops with advanced age, contributes significantly to cardiovascular risk. The present study aimed to use F-FDG/F-NaF-PET/CT imaging to, respectively, gauge arterial inflammation and microcalcification in a healthy elderly population and to assess the potential benefits of a tyrosol- and hydroxytyrosol-rich diet on these two markers of atherosclerotic plaque fragility. Eleven healthy participants (mean age 75 ± 5.67 years) were supplemented for 6 months with high polyphenol-rich extra virgin olive oil (HP-EVOO), extra virgin olive oil (EVOO), or refined olive oil (ROO). The participants underwent PET/CT imaging with F-FDG and F-NaF radiotracers at baseline and after 6 months. F-FDG and F-NaF uptakes were quantified using standardized uptake values (SUV) and were categorized based on artery calcification and olive oil type. A total of 324 slices of the aortas of the imaged participants were analyzed for arterial inflammation and 327 slices were analyzed for microcalcification. F-FDG uptake was significantly higher in the non-calcified segments than in the calcified segments (SUVmax = 2.70 ± 0.62 and SUVmax = 2.54 ± 0.44, respectively, < 0.042). Conversely, the non-calcified segments displayed significantly lower F-NaF uptake than the calcified segments (SUVmax = 1.90 ± 0.37 and 2.09 ± 0.24, respectively, < 0.0001). The 6-month supplementation with HP-EVOO induced a significant reduction in F-FDG uptake in both the non-calcified (2.93 ± 0.23 to 2.75 ± 0.38, < 0.004) and calcified segments of the aortas (2.25 ± 0.29 to 2.15 ± 0.19, < 0.02). F-NaF uptake was also significantly lower in patients supplemented with HP-EVOO (SUVmax = 1.98 ± 0.33 at baseline compared to 1.85 ± 0.28, after the 6-month supplementation, < 0.004), whereas no significant effect was observed with EVOO. Conversely, participants supplemented with ROO displayed a significant increase in F-NaF uptake (SUVmax = 1.78 ± 0.34 to 1.95 ± 0.34, < 0.0001). The present study confirmed that a phenolic-compound-rich diet reduces both arterial inflammation and atherosclerotic lesion microcalcification and demonstrated that F-FDG/F-NaF-PET/CT imaging is a valuable approach for assessing age-related arterial damage.

Citing Articles

Improving the Biostability of Extra Virgin Olive Oil with Olive Fruit Extract During Prolonged Deep Frying.

Mehany T, Gonzalez-Saiz J, Pizarro C Foods. 2025; 14(2).

PMID: 39856925 PMC: 11765049. DOI: 10.3390/foods14020260.


Role of naringin in the treatment of atherosclerosis.

Lu Y, Li D, Xu J, Zhou S Front Pharmacol. 2024; 15:1451445.

PMID: 39309005 PMC: 11412885. DOI: 10.3389/fphar.2024.1451445.


Extra Virgin Olive Oil and Metabolic Diseases.

Tsimihodimos V, Psoma O Int J Mol Sci. 2024; 25(15).

PMID: 39125686 PMC: 11312192. DOI: 10.3390/ijms25158117.


Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress.

Ballester-Servera C, Alonso J, Canes L, Vazquez-Sufuentes P, Garcia-Redondo A, Rodriguez C Antioxidants (Basel). 2024; 13(5).

PMID: 38790628 PMC: 11118817. DOI: 10.3390/antiox13050523.


Examination of Primary and Secondary Metabolites Associated with a Plant-Based Diet and Their Impact on Human Health.

Simsek M, Whitney K Foods. 2024; 13(7).

PMID: 38611326 PMC: 11011468. DOI: 10.3390/foods13071020.


References
1.
Gabbia D, Carpi S, Sarcognato S, Zanotto I, Sayaf K, Colognesi M . The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs. Biomed Pharmacother. 2022; 157:114014. DOI: 10.1016/j.biopha.2022.114014. View

2.
Li Z, Lin C, Cai X, Hu S, Lv F, Yang W . Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials. Atherosclerosis. 2023; 379:117181. DOI: 10.1016/j.atherosclerosis.2023.06.972. View

3.
Martinez-Gonzalez M, Sayon-Orea C, Bullon-Vela V, Bes-Rastrollo M, Rodriguez-Artalejo F, Yusta-Boyo M . Effect of olive oil consumption on cardiovascular disease, cancer, type 2 diabetes, and all-cause mortality: A systematic review and meta-analysis. Clin Nutr. 2022; 41(12):2659-2682. DOI: 10.1016/j.clnu.2022.10.001. View

4.
Ferrucci L, Fabbri E . Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018; 15(9):505-522. PMC: 6146930. DOI: 10.1038/s41569-018-0064-2. View

5.
Santarelli R, Pompili C, Gilardini Montani M, Evangelista L, Gonnella R, Cirone M . 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells. Pharmaceutics. 2022; 14(3). PMC: 8948646. DOI: 10.3390/pharmaceutics14030663. View